DE2655500C2 - - Google Patents

Info

Publication number
DE2655500C2
DE2655500C2 DE2655500A DE2655500A DE2655500C2 DE 2655500 C2 DE2655500 C2 DE 2655500C2 DE 2655500 A DE2655500 A DE 2655500A DE 2655500 A DE2655500 A DE 2655500A DE 2655500 C2 DE2655500 C2 DE 2655500C2
Authority
DE
Germany
Prior art keywords
deoxy
compound
carbamoyl
water
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2655500A
Other languages
German (de)
English (en)
Other versions
DE2655500A1 (de
Inventor
Gerhard Dr. Bettingen Ch Baschang
Albert Dr. 7889 Grenzach De Hartmann
Jaroslav Dr. Birsfelden Ch Stanek
Alex Muttenz Ch Sele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2655500A1 publication Critical patent/DE2655500A1/de
Application granted granted Critical
Publication of DE2655500C2 publication Critical patent/DE2655500C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19762655500 1975-12-10 1976-12-08 Glucosaminderivate und ein verfahren zu deren herstellung Granted DE2655500A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
DE2655500A1 DE2655500A1 (de) 1977-06-23
DE2655500C2 true DE2655500C2 (xx) 1988-12-22

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762655500 Granted DE2655500A1 (de) 1975-12-10 1976-12-08 Glucosaminderivate und ein verfahren zu deren herstellung

Country Status (30)

Country Link
JP (1) JPS5273820A (xx)
AR (2) AR224091A1 (xx)
AT (1) AT365607B (xx)
AU (1) AU508764B2 (xx)
BE (1) BE849214A (xx)
CA (1) CA1262400A (xx)
CH (2) CH613709A5 (xx)
CS (4) CS205028B2 (xx)
DD (1) DD129781A5 (xx)
DE (1) DE2655500A1 (xx)
DK (1) DK154654C (xx)
ES (2) ES454118A1 (xx)
FI (1) FI64164C (xx)
FR (1) FR2361902A1 (xx)
GB (1) GB1570625A (xx)
GR (1) GR61647B (xx)
HK (1) HK32883A (xx)
HU (1) HU177970B (xx)
IE (1) IE44190B1 (xx)
IL (1) IL51076A (xx)
MY (1) MY8400123A (xx)
NL (1) NL7613666A (xx)
NO (1) NO144850C (xx)
NZ (1) NZ182837A (xx)
PL (4) PL112672B1 (xx)
PT (1) PT65946B (xx)
SE (1) SE445923B (xx)
SG (1) SG11083G (xx)
SU (3) SU660589A3 (xx)
ZA (1) ZA767333B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
DE3070457D1 (en) * 1979-10-02 1985-05-15 Ciba Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (xx) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
US7838685B2 (en) 2005-04-27 2010-11-23 Shinji Takeoka Cationic amino acid type lipid
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2017098529A1 (en) 2015-12-10 2017-06-15 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
CA3072735A1 (en) 2017-08-21 2019-02-28 Celgene Corporation Processes for the preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
ZA767333B (en) 1977-11-30
IE44190L (en) 1977-06-10
DE2655500A1 (de) 1977-06-23
DK154654C (da) 1989-05-08
FI763541A (xx) 1977-06-11
ES465514A1 (es) 1978-09-16
IL51076A0 (en) 1977-02-28
FR2361902A1 (fr) 1978-03-17
SE445923B (sv) 1986-07-28
PT65946B (en) 1978-06-14
DD129781A5 (de) 1978-02-08
NO144850C (no) 1981-11-25
NO764191L (xx) 1977-06-13
CS205027B2 (en) 1981-04-30
CS205028B2 (en) 1981-04-30
SE7613851L (sv) 1977-06-11
FR2361902B1 (xx) 1980-11-07
MY8400123A (en) 1984-12-31
JPS5273820A (en) 1977-06-21
AT365607B (de) 1982-02-10
ATA909276A (de) 1981-06-15
BE849214A (fr) 1977-06-09
AR220686A1 (es) 1980-11-28
IE44190B1 (en) 1981-09-09
NZ182837A (en) 1978-07-28
HK32883A (en) 1983-09-02
DK552476A (da) 1977-06-11
AU508764B2 (en) 1980-04-03
PT65946A (en) 1977-01-01
PL194291A1 (pl) 1978-10-23
JPS638118B2 (xx) 1988-02-19
SU660589A3 (ru) 1979-04-30
PL112672B1 (en) 1980-10-31
ES454118A1 (es) 1978-03-01
PL110787B1 (en) 1980-07-31
PL110353B1 (en) 1980-07-31
NO144850B (no) 1981-08-17
AU2042276A (en) 1978-06-15
IL51076A (en) 1980-09-16
CH614718A5 (en) 1979-12-14
AR224091A1 (es) 1981-10-30
CA1262400A (en) 1989-10-17
HU177970B (en) 1982-02-28
FI64164B (fi) 1983-06-30
SG11083G (en) 1983-09-16
PL110794B1 (en) 1980-07-31
CS205025B2 (en) 1981-04-30
CH613709A5 (en) 1979-10-15
CS205026B2 (en) 1981-04-30
NL7613666A (nl) 1977-06-14
FI64164C (fi) 1983-10-10
SU1060118A3 (ru) 1983-12-07
DK154654B (da) 1988-12-05
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
SU747430A3 (ru) 1980-07-23

Similar Documents

Publication Publication Date Title
DE2655500C2 (xx)
EP0206037B1 (de) N-(2-Aminoacylamido-2-desoxy-hexosyl)-amide, -carbamate und -harnstoffe, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0025495B1 (de) Lipophile Muramylpeptide, Verfahren zu deren Herstellung und deren Verwendung
DE2728324C2 (xx)
EP0688789B1 (de) Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0027258B1 (de) Phosphorylmuramylpeptide, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
EP0114787A2 (de) Neue Peptidderivate
EP0014815A2 (de) Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3836006A1 (de) Monophosphoryllipid-a-derivate und verfahren zu deren herstellung
EP0003833B2 (de) Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
DE69704057T2 (de) Terphenylverbindungen und sie enthaltende arzneimittel
DD159341A5 (de) Derivate von aldohexosen,zwischenprodukte,verfahren zu ihrer herstellung,praeparate enthaltend solche verbindungen und ihre verwendung
US4310514A (en) Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0099578A1 (de) Neue Muramylpeptide und Verfahren zu ihrer Herstellung
DE3024355A1 (de) Neue dipeptide, verfahren zu deren herstellung und diese enthaltende arzneimittel
US4866035A (en) Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use
AT373266B (de) Verfahren zur herstellung neuer glucosederivate
EP0144894A2 (de) Pharmazeutische Verwendung von substituierten O-Acyl-glycosiden
EP0005682B1 (de) Silyl-glucosaminderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0163286A2 (de) Acylierte Zuckerderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AT373265B (de) Verfahren zur herstellung neuer glucosederivate
AT373267B (de) Verfahren zur herstellung neuer glucosederivate
EP0050703A2 (de) Neue Glucosederivate und Verfahren zu ihrer Herstellung
DE3415100A1 (de) Neue 2,3-diamino-2,3-didesoxyhexosederivate, verfahren zu ihrer herstellung und ihre verwendung
WO1995006653A1 (de) Glycosylamide von 6-amino-6-desoxy-zuckern

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: REDIES, B., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 40

Q176 The application caused the suspense of an application

Ref document number: 2718010

Country of ref document: DE

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee